Mercer Global Advisors Inc Revance Therapeutics, Inc. Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 10,278 shares of RVNC stock, worth $26,414. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,278

Previous 18,300 43.84%

Holding current value

$26,414

Previous $47,000 44.68%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.57 - $2.57 $20,616 - $20,616	-8,022 Reduced 43.84%	10,278 $26,000
Q2 2024 Aug 12, 2024	BUY	$2.34 - $4.73 $74 - $151	32 Added 0.18%	18,300 $47,000
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $930 - $1,862	200 Added 1.11%	18,268 $90,000
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $203 - $392	-35 Reduced 0.19%	18,068 $159,000
Q3 2023 Nov 13, 2023	BUY	$11.47 - $25.07 $102,564 - $224,175	8,942 Added 97.61%	18,103 $208,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $2,470 - $3,761	100 Added 1.1%	9,161 $231,000
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $37,344 - $71,739	-2,034 Reduced 18.33%	9,061 $291,000
Q4 2022 Feb 08, 2023	BUY	$18.32 - $30.66 $5,294 - $8,860	289 Added 2.67%	11,095 $205,000
Q3 2022 Nov 15, 2022	BUY	$14.33 - $28.47 $1,017 - $2,021	71 Added 0.66%	10,806 $292,000
Q2 2022 Aug 10, 2022	SELL	$11.52 - $20.4 $22,993 - $40,718	-1,996 Reduced 15.68%	10,735 $148,000
Q1 2022 May 10, 2022	SELL	$12.36 - $20.31 $95,579 - $157,057	-7,733 Reduced 37.79%	12,731 $248,000
Q4 2021 Feb 04, 2022	SELL	$12.46 - $27.87 $38,464 - $86,034	-3,087 Reduced 13.11%	20,464 $334,000
Q2 2021 Aug 10, 2021	SELL	$26.8 - $31.84 $125,986 - $149,679	-4,701 Reduced 16.64%	23,551 $698,000
Q1 2021 May 11, 2021	SELL	$24.03 - $29.97 $62,886 - $78,431	-2,617 Reduced 8.48%	28,252 $790,000
Q4 2020 Feb 12, 2021	BUY	$23.41 - $28.34 $722,643 - $874,827	30,869 New	30,869 $875,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Revance Therapeutics, Inc. Transaction History